Alisha Roy Edakkarote

Taxanes versus platinum derivatives for ovarian cancer: a comparative disproportionality analysis using the FDA adverse event reporting system database.

Signals were identified for both drug classes across multiple SOCs, with gastrointestinal and general disorders and administration site conditions most frequently reported, suggesting the usefulness of FAERS data mining in identifying signals.